Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies. (2022)

First Author: Beaton L
Attributed to:  Tracking hydrogel therapeutics using quantitative whole-body imaging funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jvir.2022.04.033

PubMed Identifier: 35526675

Publication URI: http://europepmc.org/abstract/MED/35526675

Type: Journal Article/Review

Volume: 33

Parent Publication: Journal of vascular and interventional radiology : JVIR

Issue: 9

ISSN: 1051-0443